rs35021217
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001287.6(CLCN7):c.2073+16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0918 in 1,553,366 control chromosomes in the GnomAD database, including 7,469 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.068 ( 453 hom., cov: 33)
Exomes 𝑓: 0.094 ( 7016 hom. )
Consequence
CLCN7
NM_001287.6 intron
NM_001287.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.60
Publications
8 publications found
Genes affected
CLCN7 (HGNC:2025): (chloride voltage-gated channel 7) The product of this gene belongs to the CLC chloride channel family of proteins. Chloride channels play important roles in the plasma membrane and in intracellular organelles. This gene encodes chloride channel 7. Defects in this gene are the cause of osteopetrosis autosomal recessive type 4 (OPTB4), also called infantile malignant osteopetrosis type 2 as well as the cause of autosomal dominant osteopetrosis type 2 (OPTA2), also called autosomal dominant Albers-Schonberg disease or marble disease autosoml dominant. Osteopetrosis is a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. OPTA2 is the most common form of osteopetrosis, occurring in adolescence or adulthood. [provided by RefSeq, Jul 2008]
CLCN7 Gene-Disease associations (from GenCC):
- autosomal dominant osteopetrosis 2Inheritance: AD, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics
- autosomal recessive osteopetrosis 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Genomics England PanelApp, Ambry Genetics
- hypopigmentation, organomegaly, and delayed myelination and developmentInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- autosomal recessive osteopetrosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal recessive osteopetrosis 6Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-1447639-G-A is Benign according to our data. Variant chr16-1447639-G-A is described in ClinVar as Benign. ClinVar VariationId is 257955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0984 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CLCN7 | NM_001287.6 | c.2073+16C>T | intron_variant | Intron 22 of 24 | ENST00000382745.9 | NP_001278.1 | ||
| CLCN7 | NM_001114331.3 | c.2001+16C>T | intron_variant | Intron 21 of 23 | NP_001107803.1 | |||
| CLCN7 | XM_011522354.2 | c.1899+16C>T | intron_variant | Intron 22 of 24 | XP_011520656.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0685 AC: 10424AN: 152154Hom.: 453 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
10424
AN:
152154
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0647 AC: 10028AN: 154990 AF XY: 0.0646 show subpopulations
GnomAD2 exomes
AF:
AC:
10028
AN:
154990
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0943 AC: 132104AN: 1401094Hom.: 7016 Cov.: 35 AF XY: 0.0924 AC XY: 63870AN XY: 691446 show subpopulations
GnomAD4 exome
AF:
AC:
132104
AN:
1401094
Hom.:
Cov.:
35
AF XY:
AC XY:
63870
AN XY:
691446
show subpopulations
African (AFR)
AF:
AC:
845
AN:
31730
American (AMR)
AF:
AC:
2014
AN:
36152
Ashkenazi Jewish (ASJ)
AF:
AC:
2202
AN:
25194
East Asian (EAS)
AF:
AC:
7
AN:
35988
South Asian (SAS)
AF:
AC:
2567
AN:
79452
European-Finnish (FIN)
AF:
AC:
2725
AN:
48026
Middle Eastern (MID)
AF:
AC:
465
AN:
5698
European-Non Finnish (NFE)
AF:
AC:
115964
AN:
1080764
Other (OTH)
AF:
AC:
5315
AN:
58090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
7757
15514
23272
31029
38786
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4280
8560
12840
17120
21400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0684 AC: 10419AN: 152272Hom.: 453 Cov.: 33 AF XY: 0.0638 AC XY: 4752AN XY: 74466 show subpopulations
GnomAD4 genome
AF:
AC:
10419
AN:
152272
Hom.:
Cov.:
33
AF XY:
AC XY:
4752
AN XY:
74466
show subpopulations
African (AFR)
AF:
AC:
1181
AN:
41574
American (AMR)
AF:
AC:
1184
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
294
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5170
South Asian (SAS)
AF:
AC:
170
AN:
4820
European-Finnish (FIN)
AF:
AC:
513
AN:
10614
Middle Eastern (MID)
AF:
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6826
AN:
67992
Other (OTH)
AF:
AC:
162
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
519
1038
1557
2076
2595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
48
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.